Valve-in-valve (ViV) transcatheter procedures for a failed aortic bioprosthesis are associated with a lower risk of in-hospital mortality compared with a repeat surgical aortic valve replacement, but ...
WASHINGTON, DC—Amid growing calls to consider coronary access as part of heart team discussions, a new analysis is shining a light on which devices will not impair subsequent coronary procedures and ...